Xylem (XYL) Asset Writedowns and Impairment (2011 - 2025)

Xylem's Asset Writedowns and Impairment history runs 10 years deep, the most recent figure standing at $2.0 million for Q2 2025.

• On a quarterly basis, Asset Writedowns and Impairment fell 84.62% year-over-year to $2.0 million in Q2 2025; TTM through Mar 2026 was $2.0 million, a 91.3% decrease from a year earlier, with the FY2025 full-year figure at $8.0 million, up 14.29% from the prior year.
• Asset Writedowns and Impairment fell to $2.0 million in Q2 2025 per XYL's latest filing, from $4.0 million in the prior quarter.
• Across five years, Asset Writedowns and Impairment topped out at $14.0 million in Q3 2022 and bottomed at $1.0 million in Q1 2021.
• The 5-year median for Asset Writedowns and Impairment is $1.5 million (2021), against an average of $3.9 million.
• Across the five-year window, Asset Writedowns and Impairment plunged 92.86% in 2023 and surged 500.0% in 2024, its largest moves.
• Year by year, Asset Writedowns and Impairment stood at $1.0 million in 2021, then changed by 0.0% to $1.0 million in 2022, then changed by 0.0% to $1.0 million in 2023, then jumped by 500.0% to $6.0 million in 2024, then sank by 66.67% to $2.0 million in 2025.
• Per Business Quant, the three latest XYL Asset Writedowns and Impairment figures stand at $2.0 million (Q2 2025), $4.0 million (Q1 2025), and $6.0 million (Q4 2024).